Alda-1 alleviates the cognitive deficits in D-galactose-induced aging mice by regulating oxidative stress, neuroinflammation, and mitochondrial biogenesis
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 06.10.2026 · 81 (11)
DOI: 10.1093/gerona/glag241 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 25.09.2026. Verfasst von Tengfei Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Affiliated Hospital, Hebei University of Engineering, Handan, China. Hauptthemen laut MEDLINE: Oxidative Stress, Organelle Biogenesis, Aging, Cognitive Dysfunction. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Hebei University of Engineering Innovation Fund Project.
Abstract (Originalsprache)
Although mitochondrial aldehyde dehydrogenase 2 (ALDH2) is involved in aging and age-related neurodegenerative diseases, the impact of ALDH2 on age-related cognitive deficits and its underlying mechanisms have not been fully elucidated. This study aimed to explore the effects of ALDH2 on cognitive deficits in D-galactose-induced aging mice and illustrate the potential molecular mechanisms. We treated D-galactose-induced aging mice with Alda-1 (a potent agonist of ALDH2) for 8 weeks and observed the alterations in behavior, levels of oxidative stress and neuroinflammation, mitochondrial function, and expression of mitochondrial biogenesis-related genes. The results revealed that Alda-1 alleviated neuropathological changes in the hippocampus and ameliorated cognitive deficits in D-galactose-induced aging mice. Administration of Alda-1 further reduced the levels of 4-HNE, MDA, 3-NT, IL-6, TNF-α, and IL-1β; enhanced Mn-SOD and CAT activities; increased GSH and ATP levels and mitochondrial content; and upregulated PGC-1α/NRF-1/TFAM expression in the hippocampus of D-galactose-induced aging mice. Moreover, in D-galactose-treated HT22 cells, we found that the SIRT1 inhibitor EX527 reversed the Alda-1-induced upregulation of PGC-1α, suggesting that the Alda-1-induced upregulation of PGC-1α is associated with SIRT1 signaling. Collectively, Alda-1 ameliorated cognitive deficits in D-galactose-induced aging mice by reducing neuroinflammation, enhancing antioxidative capability, promoting mitochondrial biogenesis, and modulating the SIRT1/PGC-1α signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Affiliated Hospital, Hebei University of Engineering, Handan, China.
- South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China.
ORCID-Profile: Hexin Yan
Förderung
- Hebei University of Engineering Innovation Fund Project
Zitieren
APA
Liang, T., Wang, L., Kang, S., Pang, X., & Yan, H. (2026). Alda-1 alleviates the cognitive deficits in D-galactose-induced aging mice by regulating oxidative stress, neuroinflammation, and mitochondrial biogenesis. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(11). https://doi.org/10.1093/gerona/glag241
Vancouver
Liang T, Wang L, Kang S, Pang X, Yan H. Alda-1 alleviates the cognitive deficits in D-galactose-induced aging mice by regulating oxidative stress, neuroinflammation, and mitochondrial biogenesis. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(11). doi:10.1093/gerona/glag241
BibTeX
@article{Liang2026,
author = {Liang, Tengfei and Wang, Lixia and Kang, Shujuan and Pang, Xiaoyan and Yan, Hexin},
title = {Alda-1 alleviates the cognitive deficits in D-galactose-induced aging mice by regulating oxidative stress, neuroinflammation, and mitochondrial biogenesis},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {11},
doi = {10.1093/gerona/glag241}
}
EUVIMED